United States:
ML Strategies Health Care Preview – July 16, 2018
To print this article, all you need is to be registered or login on Mondaq.com.
Congress is in session this week with six important health care
hearings, including hearings on Medicare fraud, mental health, and
Stark reform. Meanwhile, the Administration continues to put forth
new proposed rules and guidance that will impact many
stakeholders between now and the end of the year. We cover this and
more in this week's health care preview, which you can find by
clicking here.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...